GSPT1 and pancreatic adenocarcinoma: To evaluate the effect of ERF3A loss on the pancreatic adenocarcinoma cell growth, these 20 cell lines were seeded at low density, after which the number of viable cells was determined over time using the CellTiter Glo reagent.